What top creators are saying about Nautilus Biotechnology, Inc.(NAUT)
Biotechnology company developing a single-molecule protein analysis platform.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Based on 1 scored insight about Nautilus Biotechnology, Inc..
Top creators covering Nautilus Biotechnology, Inc. (NAUT)
The 1 sources with the most insights about Nautilus Biotechnology, Inc. on Kazuha.
Latest insights about Nautilus Biotechnology, Inc. (NAUT)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Yesterday
The speaker was skeptical, questioning whether it was a drug company and citing quarterly revenue of about $190,000.
Yesterday
The speaker was skeptical, questioning whether it was a drug company and citing quarterly revenue of about $190,000.
Discussed alongside Nautilus Biotechnology, Inc. (NAUT)
Other assets that creators frequently mention in the same content as Nautilus Biotechnology, Inc..
Frequently asked
Which podcasters and creators cover Nautilus Biotechnology, Inc. (NAUT) the most?
The most active sources covering Nautilus Biotechnology, Inc. (NAUT) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Nautilus Biotechnology, Inc. (NAUT) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Nautilus Biotechnology, Inc. (NAUT) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Nautilus Biotechnology, Inc. (NAUT)?
Creators covering Nautilus Biotechnology, Inc. (NAUT) most frequently also discuss ASML, LQDA, Cerebras Systems, Inc., INTC, AMD. See the "Discussed alongside" section above for full asset pages.